Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Jun 20 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

We hereby attaching you the intimation under regulation 31A(10) of SEBI(LODR) Regulation, 2015 for reclassification of promoter to public pursuant to open offer.

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases